Skip to main content
Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
71.39
-0.23 (-0.32%)
At close: Mar 3, 2025, 4:00 PM
71.80
+0.41 (0.57%)
Pre-market: Mar 4, 2025, 5:46 AM EST

Edwards Lifesciences Revenue by Segment
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Transcatheter Aortic Valve Replacement
4.05B 3.99B 3.94B 3.88B 3.77B 3.67B 3.58B 3.52B
Transcatheter Aortic Valve Replacement Growth
7.46% 8.65% 9.90% 10.28% 6.99% 4.32% 2.07% 2.80%
Surgical Structural Heard
1.02B 1.03B 1.02B 999.30M 975.20M 948.30M 920.50M 893.10M
Surgical Structural Heard Growth
4.45% 8.11% 10.51% 11.89% 9.54% 6.79% 2.63% 0.45%
Transcatheter Mitral and Tricuspid Therapies
303.00M 264.30M 228.90M 197.60M 173.10M 150.40M 130.70M 116.10M
Transcatheter Mitral and Tricuspid Therapies Growth
75.04% 75.73% 75.13% 70.20% 57.51% 46.73% 35.16% 35.00%
Critical Care
- - 957.50M 928.10M 902.60M 888.90M 864.80M 855.00M
Critical Care Growth
- - 10.72% 8.55% 7.25% 4.95% 1.57% 2.41%

Revenue by Geography
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
United States
3.46B 3.52B 3.60B 3.51B 3.41B 3.33B 3.23B 3.13B
United States Growth
1.37% 5.86% 11.39% 12.01% 10.83% 9.32% 6.40% 5.72%
Europe
1.37B 1.37B 1.37B 1.33B 1.28B 1.23B 1.19B 1.17B
Europe Growth
6.85% 11.59% 14.76% 13.59% 7.29% 1.14% -2.18% -1.30%
Rest of World
656.40M 688.10M 722.80M 709.20M 677.30M 655.00M 621.60M 601.40M
Rest of World Growth
-3.09% 5.05% 16.28% 17.92% 14.33% 14.03% 9.88% 9.31%
Japan
391.60M 418.60M 449.10M 452.40M 451.50M 447.20M 452.20M 473.60M
Japan Growth
-13.27% -6.40% -0.69% -4.48% -9.95% -14.53% -15.02% -10.46%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.